# AI for Clinical Trials

## Description

Machine learning for clinical-trial design, patient eligibility, cohort selection, outcome prediction, and operational monitoring across the trial lifecycle.

## When to use

You are designing a clinical trial, forecasting enrollment, selecting eligible participants, or monitoring safety and operational metrics during trial conduct.

## Usage

- **Trial feasibility**: predict enrollment, dropout, and site performance.
- **Eligibility screening**: parse unstructured criteria and match patients to protocols.
- **Outcome prediction**: forecast treatment response and safety events.
- **Site and data monitoring**: detect anomalies, drift, and data-quality issues.

## Steps

1. Translate the protocol into structured eligibility and endpoint definitions.
2. Link EHR or registry data to candidate participants using structured and NLP features.
3. Build and validate prediction models for enrollment, response, or adverse events.
4. Deploy models under prospective monitoring with human oversight.
5. Retrain and validate when protocols, sites, or populations change.

## Code pattern

```python
import pandas as pd
from sklearn.ensemble import GradientBoostingClassifier

# Structured eligibility and baseline features
X = trial_df[["age", "stage", "prior_therapies", "ecog", "biomarker"]]
y = trial_df["eligible"]

clf = GradientBoostingClassifier(random_state=42).fit(X, y)
trial_df["eligible_score"] = clf.predict_proba(X)[:, 1]
```

## Tuning notes

- Ensure eligibility models use only pre-screening data and avoid outcome leakage.
- Validate on held-out sites to test generalizability across centers.
- Monitor for protocol drift and eligibility-criteria creep over time.
- Maintain audit trails and regulatory documentation for AI-derived decisions.

## Verification

1. Compare an ML eligibility screener to manual chart review on a validation set.
2. Forecast enrollment for a trial and compare to actual accrual.
3. Run a simulated sensitivity analysis for protocol amendments and drift.

## References

- https://trialsjournal.biomedcentral.com/counter/pdf/10.1186/s13063-021-05489-x.pdf
- https://www.nature.com/articles/s41571-026-01189-0
- https://www.nature.com/articles/s41467-026-74501-2
- https://pmc.ncbi.nlm.nih.gov/articles/PMC11319878/
